3D Scaffold Composition with Entrapped ECM Proteins
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing 3D scaffolds for cell and tissue growth face challenges such as poor cell viability, batch-to-batch variability, and lack of controlled mechanical and chemical properties, particularly when using synthetic or semi-synthetic polymers or naturally-derived materials like Matrigel.
Innovation Solution
A composition comprising a biocompatible polymer and a modified extracellular matrix (ECM) protein, where the modified ECM protein is entrapped within the scaffold material without covalent cross-linking, using a synthetic linker and a blocking group that does not react with the polymer during polymerization.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If synthetic or semi-synthetic polymers are used to prepare 3D scaffolds, then the scaffolds have controlled physical properties and composition, but they provide a poor environment for cell or tissue growth
Solution Approach 1:
The patent combines synthetic polymers (such as PEG, GelMA) with natural extracellular matrix components (collagen, elastin, laminin, fibronectin) to create composite scaffold materials. This allows the scaffold to simultaneously achieve controlled physical properties from the synthetic polymer and biocompatibility with cell growth from the natural ECM components, resolving the contradiction between manufacturing precision and biological functionality.
2Reliability
If naturally-derived materials like Matrigel are used, then the scaffolds mimic the native extracellular matrix environment, but they have significant batch-to-batch variability and lack of controlled physical properties
Solution Approach 1:
The patent segments the scaffold composition into distinct functional components: a synthetic polymer matrix providing controlled physical properties and mechanical strength, and separate natural ECM components providing biological activity. This segmentation allows independent optimization and control of each component's properties, eliminating batch variability while maintaining ECM mimicry.
Solution Approach 2:
The patent employs parameter changes by systematically adjusting the ratio, concentration, and molecular weight of different components (synthetic polymer to natural ECM ratio, degree of crosslinking, hydrogel concentration) to achieve both controlled physical properties and reliable biological functionality, thereby eliminating batch-to-batch variability.
3Strength
If native fibronectin is incorporated into synthetic scaffolds, then the scaffold provides structural support, but the protein is rapidly released from the scaffold
Solution Approach 1:
The patent introduces an intermediary mechanism such as covalent crosslinking, affinity binding, or physical entrapment within the hydrogel matrix to retain fibronectin and other ECM proteins within the scaffold. This intermediary approach prevents rapid protein release while maintaining the structural support function, resolving the contradiction between strength and compositional stability.
4Reliability
If isolated extracellular matrix components are derivatised and covalently bound to the scaffold, then the scaffold retains biological activities, but the process increases complexity
Solution Approach 1:
The patent applies preliminary action by pre-modifying the synthetic polymer with functional groups (such as carboxyl, amine, or hydroxyl groups) before incorporating natural ECM components. This preliminary functionalization enables straightforward covalent or non-covalent attachment of ECM proteins without requiring complex multi-step derivation processes, thereby reducing overall process complexity while maintaining biological activity retention.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The resulting 3D scaffold provides excellent cell viability, retains the biological function of the ECM proteins, acts as a reservoir for growth factors, and can be reproducibly fabricated using 3D bioprinting techniques, addressing the limitations of existing scaffolds.
Implementation Method 1
a biocompatible polymer suitable for the preparation of a hydrogel
Implementation Method 2
the modified ECM protein is entrapped within the scaffold material without covalent cross-linking
Data Source
AI summary
The invention relates to a composition for preparing a 3D scaffold for culturing cells and tissue, such as human cells and tissue. In particular embodiments, the present invention relates to a composition comprising a biocompatible polymer suitable for the preparation of a hydrogel, and a modified extracellular matrix (ECM) protein that is unreactive towards the biocompatible polymer, such that, after preparation of a hydrogel, the modified ECM protein is not covalently bound to the hydrogel. Compositions of the invention are suitable for use in 3D bioprinting, tissue engineering, drug screening, disease modelling and methods of treatment such as tissue regeneration.